Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 SGD | -33.33% | -33.33% | 0.00% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 14.65 | 6.706 | 15.65 | 12.8 | 41.36 | 14.93 |
Enterprise Value (EV) 2 | 6.271 | 6.896 | 15.72 | 13.28 | 44.01 | 20.37 |
P/E ratio | 0.7 x | -0.68 x | -2.01 x | -2.89 x | -4.62 x | -4.05 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.31 x | 0.84 x | 28.1 x | - | 4.41 x | 1.14 x |
EV / Revenue | 0.56 x | 0.87 x | 28.2 x | - | 4.7 x | 1.56 x |
EV / EBITDA | -0.45 x | -0.75 x | -2.23 x | -6.04 x | -14.2 x | -8.81 x |
EV / FCF | -0.26 x | -1.35 x | -4.67 x | -13.3 x | -255 x | 192 x |
FCF Yield | -384% | -74.2% | -21.4% | -7.53% | -0.39% | 0.52% |
Price to Book | 0.83 x | 0.79 x | 20.8 x | -7.2 x | -21.6 x | -3.87 x |
Nbr of stocks (in thousands) | 20,92,632 | 22,35,272 | 22,35,272 | 25,59,739 | 68,93,073 | 74,64,501 |
Reference price 3 | 0.007000 | 0.003000 | 0.007000 | 0.005000 | 0.006000 | 0.002000 |
Announcement Date | 14/04/19 | 18/07/20 | 15/04/21 | 14/04/22 | 12/04/23 | 12/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 11.16 | 7.954 | 0.557 | - | 9.368 | 13.08 |
EBITDA 1 | -13.9 | -9.236 | -7.058 | -2.198 | -3.089 | -2.313 |
EBIT 1 | -14.22 | -9.343 | -7.127 | -2.267 | -3.419 | -2.791 |
Operating Margin | -127.32% | -117.46% | -1,279.53% | - | -36.5% | -21.34% |
Earnings before Tax (EBT) 1 | 29.57 | -9.643 | -7.575 | -3.94 | -8.516 | -3.281 |
Net income 1 | 29.57 | -9.643 | -7.577 | -3.913 | -8.541 | -3.621 |
Net margin | 264.86% | -121.23% | -1,360.32% | - | -91.17% | -27.68% |
EPS 2 | 0.0100 | -0.004441 | -0.003489 | -0.001731 | -0.001299 | -0.000494 |
Free Cash Flow 1 | -24.1 | -5.117 | -3.363 | -1 | -0.1725 | 0.1064 |
FCF margin | -215.84% | -64.33% | -603.82% | - | -1.84% | 0.81% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 14/04/19 | 18/07/20 | 15/04/21 | 14/04/22 | 12/04/23 | 12/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.19 | 0.08 | 0.49 | 2.65 | 5.44 |
Net Cash position 1 | 8.38 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -0.0206 x | -0.0106 x | -0.2207 x | -0.8569 x | -2.353 x |
Free Cash Flow 1 | -24.1 | -5.12 | -3.36 | -1 | -0.17 | 0.11 |
ROE (net income / shareholders' equity) | 1,437% | -73.6% | -163% | 674% | 409% | 149% |
ROA (Net income/ Total Assets) | -42.4% | -31.3% | -54% | -69.3% | -27% | -12.7% |
Assets 1 | -69.77 | 30.83 | 14.03 | 5.649 | 31.63 | 28.52 |
Book Value Per Share 2 | 0.0100 | 0 | 0 | -0 | -0 | -0 |
Cash Flow per Share 2 | 0.0100 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0.1 | 0.01 | - | - | 0.93 | 0.3 |
Capex / Sales | 0.87% | 0.18% | - | - | 9.88% | 2.28% |
Announcement Date | 14/04/19 | 18/07/20 | 15/04/21 | 14/04/22 | 12/04/23 | 12/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 11.83M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- V8Y Stock
- Financials Quantum Healthcare Limited